Monitor for additional insider selling; this single sale is routine and not indicative of distress, but track whether it's part of a broader trend ahead of earnings or regulatory events.
CORT drugs
CORT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 17 $33.51entry
- T+1 · 8mo ago −0.63%α +0.77% · $33.30
- T+5 · 8mo ago +0.93%α +3.58% · $33.82
- T+20 · 7mo ago +31.01%α +26.71% · $43.90
- T+60 · 5mo ago +131.24%α +121.38% · $77.49
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Chief Development Officer William Guyer exercised stock options and sold 11,767 shares in the open market for approximately $424,000. The transaction was part of a pre-arranged plan or routine post-exercise sale, with no open-market purchases observed in the cluster.
Key Financial Metrics
Key Facts
- William Guyer, Chief Development Officer, exercised 23,534 derivative securities on March 20, 2026, in two tranches: one non-cash exercise (11,767 shares at $0) and one at $21.65 per share.
- He sold 11,767 shares in the open market at $36.01, generating $423,730 in proceeds.
- Total value of open-market sale represents ~0.012% of company's $3.6B market cap, well below materiality threshold.
Financial Impact
$423,730 in open-market share sales by C-suite executive
Risk Factors
- Perception risk if viewed as insider exiting position, though likely routine option exercise and sale
- Potential for misinterpretation due to lack of public 10b5-1 plan disclosure timing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-CORT-1774385713966 |
Track record
36 reports on CORT
8 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +63.06% at T+60 after the Feb 24, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $73.87 Now $69.22 −6.29% settles Dec 15
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $74.53 Now $69.22 −7.12% settles Dec 10
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $71.63 Now $69.22 −3.36% settles Dec 4
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $79.22 Now $69.22 −12.62% settles Dec 3
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $81.93 Now $69.22 +15.51% settles Dec 2
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $86.28 Now $69.22 −19.77% settles Nov 25
- Oct 5, 20266w ago Insider Cluster Neutral 3/10 Entry $119.57 to $81.93 Now $69.22 −42.11% ▼ −31.48% −28.30% vs SPY
- Sep 23, 20267w ago 8-K Neutral 3/10 Entry $112.94 to $116.28 Now $69.22 −38.71% ▲ +2.96% +2.27% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.50% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers